LogicBio Therapeutics

LogicBio Therapeutics is a genomic editing company focused on developing therapeutics using its proprietary technology platform, GenerIDE, to provide durable treatments for rare diseases in patients with severe unmet medical needs. Its pipeline includes the product candidates LB-001, LB-101, LB-201, and LB-301.